Chr. Olesen Pharma Latin A/S — Credit Rating and Financial Key Figures

Chr. Olesen Pharma Latin A/S (CVR number: 39463989) is a company from GENTOFTE. The company recorded a gross profit of 283 kEUR in 2025. The operating profit was 192.7 kEUR, while net earnings were 107.3 kEUR. The profitability of the company measured by Return on Assets (ROA) was 6.5 %, which can be considered decent but Return on Equity (ROE) was 12.3 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 25 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Chr. Olesen Pharma Latin A/S's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.